You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

57 Results
Guidelines and Advice
Status: Archived
ID: 9-7
Mar 2013
Guidelines and Advice
Status: Current
ID: GL-C50-33
Version: 1
Aug 2017
Cancer screening can find abnormal cell changes before they become cancer or cancer at an early stage, when treatment has a better chance of working...
Genetic testing looks for mutations or variants in a person’s DNA. These tests can help: predict a person’s predisposition to disease provide...
Guidelines and Advice
Status: Current
Version: 2
Oct 2018
Guidelines and Advice
Status: Current
ID: 17-3
Version: 2
Oct 2017
Guidelines and Advice
Status: Current
Version: 2
Jul 2024
Guidelines and Advice
Status: Current
ID: ES SMG-3
Jan 2019
Guidelines and Advice
Status: Archived
ID: 15-6
Mar 2009
Guidelines and Advice
Status: Current
ID: ES SMG-2
Jun 2018
Regimen
Cancer Type:
Hematologic, 
Lymphoma - Non-Hodgkin's High Grade, 
Lymphoma - Non-Hodgkin's Intermediate Grade
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Funding:
New Drug Funding Program
    Glofitamab (Outpatient) - Relapsed or Refractory Diffuse Large B-cell Lymphoma
High Cost Therapy Funding Program
    Glofitamab (Inpatient) - Relapsed or Refractory Diffuse Large B-cell Lymphoma
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
oBINutuzumab,
glofitamab
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Sep 2024

Pages